{"title": "Merck Obtains Exclusive Rights to Market and Distribute MassBiologics' Tetanus-Diphtheria (Td) Vaccine in the U.S.", "author": null, "url": "https://www.fiercepharma.com/pharma/merck-obtains-exclusive-rights-to-market-and-distribute-massbiologics-tetanus-diphtheria-td", "hostname": "fiercepharma.com", "description": "Merck's Adult Vaccine Portfolio Now Includes 9 of the 10 Vaccines on the U.S. CDC's Recommended Adult Immunization Schedule BOSTON & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- MassBiologics | Merck's Adult Vaccine Portfolio Now Includes 9 of the 10 Vaccines on the U.S. CDC's Recommended Adult Immunization Schedule BOSTON & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- MassBiologics", "sitename": "FiercePharma", "date": "2010-04-21", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}